Investor Conference Call on the Ad-hoc message on November 7, 2003
Werner Wenning continues systematic realignment:
Bayer plans stock market flotation for chemicals activities and strategic refocus of health care businessSupervisory Board approves Management Board plans / Focus on core businesses should enhance Bayers competitiveness / New company to be positioned among Europes leading chemical enterprises / Pharmaceuticals business to be retained as stand-alone solution more
The audio recording of this event is no longer available.
|Presentation by Werner Wenning,|
CEO of Bayer AG
|Download PDF collect (356 KB)|